11 Sep 2020
Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference
Author: admintech | Filed under: Press ReleaseLA JOLLA, Calif., Sept. 11, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan, President and Chief Executive Officer of…